Strategikon Pharma
PrivateLast Round
Debt
Jun 10, 2025
Total Funding Raised
$7.03M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Strategikon Pharma is a software company that provides a cloud-based platform, Clinical Maestro, for clinical trial budgeting, sourcing, and outsourcing management.
Sector
Enterprise Software
Verticals
Clinical Trials, Vertical SaaS, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Strategikon Pharma Comparables
Compare Strategikon Pharma with similar companies based on industry and business-model similarity.
Strategikon Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jun 10, 2025 | ||||
| Series A Extension | Feb 6, 2024 | ||||
| Grant | Apr 13, 2023 | ||||
| Series A | Apr 22, 2021 | ||||
| Seed | Jan 1, 2020 |
Key People
Founding team and executive leadership
Strategikon Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Saratoga Ventures | Seed |
| Osage Venture Partners | Series A, Series A Extension |
| Decathlon Capital Partners | Debt |
| Bascom Ventures | Series A |
| Wing Venture Capital | Series A |
| Arizona Commerce Authority | Grant |
| TCA Venture Group | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 102% MoM.
- Aug 27, 2025
Launched Clinical Maestro 5.0, an upgrade to its trial management solution.
Recent news
Latest coverage and updates
- launchesSep 10, 2026
Clinical Maestro launched Source Plus on Sep 10th '26.
Strategikon Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Strategikon Pharma's valuation, stock price, and market status.
Is Strategikon Pharma a public or private company?
Strategikon Pharma is a private company.
What is the current stock price of Strategikon Pharma?
Strategikon Pharma is a private company with no public stock price. No recent secondary market data is available.
How much is Strategikon Pharma worth (valuation)?
Valuation information for Strategikon Pharma is not publicly available.
Can I buy Strategikon Pharma stock?
Strategikon Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Strategikon Pharma's last funding round?
Strategikon Pharma's most recent funding round was Debt on June 10, 2025.
Who are the main investors in Strategikon Pharma?
Key investors in Strategikon Pharma include Osage Venture Partners, Decathlon Capital Partners.
Will Strategikon Pharma IPO soon?
No public IPO plans have been announced for Strategikon Pharma.
How can I track Strategikon Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Strategikon Pharma's secondary market activity and sign up for updates.